Header Logo

Connection

Douglas Corley to United States

Back to Details
This is a "connection" page, showing publications Douglas Corley has written about United States.
Douglas Corley
Connection Strength
1.083
United States
  1. When Should Guidelines Change? A Clarion Call for Evidence Regarding the Benefits and Risks of Screening for Colorectal Cancer at Earlier Ages. Gastroenterology. 2018 10; 155(4):947-949.
    View in: PubMed
    Score: 0.087
  2. Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium. JAMA. 2016 May 17; 315(19):2067-8.
    View in: PubMed
    Score: 0.074
  3. Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors. Aliment Pharmacol Ther. 2016 Jan; 43(1):73-82.
    View in: PubMed
    Score: 0.071
  4. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr 03; 370(14):1298-306.
    View in: PubMed
    Score: 0.064
  5. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology. 2012 Apr; 142(4):744-53.
    View in: PubMed
    Score: 0.055
  6. Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Dig Dis Sci. 2009 Sep; 54(9):2031-9.
    View in: PubMed
    Score: 0.044
  7. Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am J Med. 2008 Jun; 121(6):525-31.
    View in: PubMed
    Score: 0.043
  8. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. J Natl Cancer Inst. 2015 Jun; 107(6):djv120.
    View in: PubMed
    Score: 0.034
  9. Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst. 2004 Sep 15; 96(18):1383-7.
    View in: PubMed
    Score: 0.033
  10. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol. 2004 Apr; 99(4):582-8.
    View in: PubMed
    Score: 0.032
  11. How should we select health professionals for studies? Outcomes Manag. 2003 Jul-Sep; 7(3):129-33.
    View in: PubMed
    Score: 0.030
  12. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer. 2002 Nov 15; 95(10):2096-102.
    View in: PubMed
    Score: 0.029
  13. Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines. Ann Intern Med. 2022 11; 175(11):1582-1590.
    View in: PubMed
    Score: 0.029
  14. Cancer Screening During the Coronavirus Disease-2019 Pandemic: A Perspective From the National Cancer Institute's PROSPR Consortium. Gastroenterology. 2021 03; 160(4):999-1002.
    View in: PubMed
    Score: 0.025
  15. Standardized Reporting and Management of Suspicious Findings on Chest CT Imaging Is Associated With Improved Lung Cancer Diagnosis in an Observational Study. Chest. 2020 11; 158(5):2211-2220.
    View in: PubMed
    Score: 0.024
  16. Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps. Gastroenterology. 2020 08; 159(2):502-511.e2.
    View in: PubMed
    Score: 0.024
  17. Evaluating Screening Participation, Follow-up, and Outcomes for Breast, Cervical, and Colorectal Cancer in the PROSPR Consortium. J Natl Cancer Inst. 2020 03 01; 112(3):238-246.
    View in: PubMed
    Score: 0.024
  18. Morbidity and Mortality After Surgery for Nonmalignant Colorectal Polyps: A 10-Year Nationwide Analysis. Am J Gastroenterol. 2019 11; 114(11):1802-1810.
    View in: PubMed
    Score: 0.023
  19. Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network. JCO Clin Cancer Inform. 2019 09; 3:1-10.
    View in: PubMed
    Score: 0.023
  20. Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single-payer healthcare system. Int J Urol. 2017 10; 24(10):765-770.
    View in: PubMed
    Score: 0.020
  21. Dietary sugar/starches intake and Barrett's esophagus: a pooled analysis. Eur J Epidemiol. 2017 11; 32(11):1007-1017.
    View in: PubMed
    Score: 0.020
  22. Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems. Medicine (Baltimore). 2017 Mar; 96(11):e6326.
    View in: PubMed
    Score: 0.019
  23. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach. J Gen Intern Med. 2016 10; 31(10):1190-7.
    View in: PubMed
    Score: 0.019
  24. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol. 2016 10; 14(10):1445-1451.e8.
    View in: PubMed
    Score: 0.018
  25. Colorectal Cancer Health Disparities and the Role of US Law and Health Policy. Gastroenterology. 2016 05; 150(5):1052-1055.
    View in: PubMed
    Score: 0.018
  26. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50.
    View in: PubMed
    Score: 0.018
  27. Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. Gastroenterology. 2015 Nov; 149(6):1599-606.
    View in: PubMed
    Score: 0.018
  28. Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. J Comp Eff Res. 2015 Nov; 4(6):541-51.
    View in: PubMed
    Score: 0.017
  29. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015 Jul 01; 121(13):2281-5.
    View in: PubMed
    Score: 0.017
  30. Chronic kidney disease and risk of renal cell carcinoma: differences by race. Epidemiology. 2015 Jan; 26(1):59-67.
    View in: PubMed
    Score: 0.017
  31. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015 Mar; 25(3):208-213.e1.
    View in: PubMed
    Score: 0.017
  32. Developing a data infrastructure for a learning health system: the PORTAL network. J Am Med Inform Assoc. 2014 Jul-Aug; 21(4):596-601.
    View in: PubMed
    Score: 0.016
  33. Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy. J Med Screen. 2013 Dec; 20(4):198-207.
    View in: PubMed
    Score: 0.015
  34. Prehypertension and hypertension in community-based pediatric practice. Pediatrics. 2013 Feb; 131(2):e415-24.
    View in: PubMed
    Score: 0.015
  35. The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett's Esophagus. Gastrointest Endosc. 2012 Aug; 76(2):252-4.
    View in: PubMed
    Score: 0.014
  36. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology. 2012 Mar; 142(3):442-452.e5; quiz e22-3.
    View in: PubMed
    Score: 0.014
  37. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut. 2011 Aug; 60(8):1029-37.
    View in: PubMed
    Score: 0.013
  38. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1366-72; quiz 1301.
    View in: PubMed
    Score: 0.009

© 2024 Kaiser Permanente